Evidence map›Paper›PMID 38020082›Full record

ReviewFrontiers in medicine2023

Temperature control in sepsis.

Marc Doman, Michael Thy, Julien Dessajan, Mariem Dlela, Hermann Do Rego, Erwann Cariou, Michael Ejzenberg, Lila Bouadma, Etienne de Montmollin, Jean-François Timsit

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. The poikilothermic hypothesis of sepsis.Critical care (London, England) · 2026
    Review
  3. Article
  4. Article
  5. The cycle of infectious fever - how it affects bacterial infections.Frontiers in cellular and infection microbiology · 2026
    Review
  6. Fever in Sepsis Revisited: Is a Little Heat What We Need?Open forum infectious diseases · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Severe intensive care unit-acquired hypernatraemia: Prevalence, risk factors, trajectory, management, and outcome.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2024
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Marc DomanMedical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Michael ThyMedical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Julien DessajanMedical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Mariem DlelaMedical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Hermann Do RegoMedical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Erwann CariouMedical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Michael EjzenbergMedical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Lila BouadmaMedical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Etienne de MontmollinMedical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Jean-François TimsitMedical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Université Paris Cité · FRDélégation Paris 7 · FRSorbonne Paris Cité · FRAssistance Publique – Hôpitaux de Paris · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fever can be viewed as an adaptive response to infection. Temperature control in sepsis is aimed at preventing potential harms associated with high temperature (tachycardia, vasodilation, electrolyte and water loss) and therapeutic hypothermia may be aimed at slowing metabolic activities and protecting organs from inflammation. Although high fever (>39.5°C) control is usually performed in critically ill patients, available cohorts and randomized controlled trials do not support its use to improve sepsis prognosis. Finally, both spontaneous and therapeutic hypothermia are associated with poor outcomes in sepsis.

Indexed as

antipyreticsbody temperaturefeverprognosissepsisseptic shock

Identifiers

PMID38020082
PMCPMC10644266
OpenAlexW4388043561

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.